Yan Hu
Southeast University
6 Papers
38 Citations
Yan Hu is an academic researcher from Southeast University. The author has contributed to research in topics: Erythropoietin & Logistic regression. The author has an hindex of 5, co-authored 5 publications.
Chat about Author
Papers
Erythropoietin-loaded oligochitosan nanoparticles for treatment of periventricular leukomalacia.
Ting Wang,Yan Hu,Michelle K. Leach,Long Zhang,Wenjing Yang,Li Jiang,Zhang-Qi Feng,Nongyue He +7 more
TL;DR: It is suggested that oligochitosan based nanoparticles are an effective vehicle for drug delivery in terms of therapeutic efficacy and mechanism by which epo-NPs protect white matter.
29
Recombinant human erythropoietin augments angiogenic responses in a neonatal rat model of cerebral unilateral hypoxia-ischemia.
TL;DR: The angiogenic effects of rh-EPO are shown in a rat model of neonatal cerebral unilateral hypoxia-ischemia and this results highlight the powerful therapeutic potential of rh -EPO treatment of HI premature brain for the enhancement ofAngiogenic responses.
19
Therapy for cerebral ischemic injury with erythropoietin-containing nanoparticles.
TL;DR: It was demonstrated that EPO-containing nanoparticles can ameliorate drug-induced liquefaction caused by hypoxia and may open new therapeutic strategies in Hypoxia cure.
17
Erythropoietin Nanopariticles: Therapy for Cerebral Ischemic Injury and Metabolize in Kidney and Liver
TL;DR: It is demonstrated in vivo that EPO nanocarriers can ameliorate drug-induced liquefaction caused by hypoxia and can effectively prolong the plasma half-life of EPO and slower clearance time compared to direct injection.